LIGAND PHARMACEUTICALS INCORPORATED

LGNZZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
144 Sep 3, 2026
8-K/A Sep 2, 2026 8-K/A
4 Aug 14, 2026 PRIMARY DOCUMENT
4 Aug 14, 2026 PRIMARY DOCUMENT
SCHEDULE 13G Aug 13, 2026
144 Aug 12, 2026
144 Aug 12, 2026
10-Q Aug 7, 2026 10-Q
8-K Aug 6, 2026 8-K
4 Aug 4, 2026 PRIMARY DOCUMENT
S-8 Jul 22, 2026 S-8
8-K Jul 14, 2026 8-K
4 Jul 6, 2026 PRIMARY DOCUMENT
4 Jul 6, 2026 PRIMARY DOCUMENT
4 Jul 6, 2026 PRIMARY DOCUMENT
144 Jul 1, 2026
8-K Jun 25, 2026 8-K
8-K Jun 22, 2026 8-K
4 Jun 18, 2026 OWNERSHIP DOCUMENT
144 Jun 16, 2026
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 12, 2026 PRIMARY DOCUMENT
4 Jun 12, 2026 PRIMARY DOCUMENT
144 Jun 12, 2026
144 Jun 11, 2026
← Newer Page 1 of 89 · 2208 filings Older →